Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound–Kinase Activities: A Way toward Selective Promiscuity by Design?

por Christmann-Franck, Serge, van Westen, Gerard J. P., Papadatos, George, Beltran Escudie, Fanny, Roberts, Alexander, Overington, John P., Domine, Daniel
Publicado 2016

The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern

por Abdelnabi, Rana, Foo, Caroline S., Jochmans, Dirk, Vangeel, Laura, De Jonghe, Steven, Augustijns, Patrick, Mols, Raf, Weynand, Birgit, Wattanakul, Thanaporn, Hoglund, Richard M., Tarning, Joel, Mowbray, Charles E., Sjö, Peter, Escudié, Fanny, Scandale, Ivan, Chatelain, Eric, Neyts, Johan
Publicado 2022

Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2

por Driouich, Jean-Sélim, Cochin, Maxime, Touret, Franck, Petit, Paul-Rémi, Gilles, Magali, Moureau, Grégory, Barthélémy, Karine, Laprie, Caroline, Wattanakul, Thanaporn, Chotsiri, Palang, Hoglund, Richard M., Tarning, Joel, Fraisse, Laurent, Sjö, Peter, Mowbray, Charles E., Escudié, Fanny, Scandale, Ivan, Chatelain, Eric, de Lamballerie, Xavier, Solas, Caroline, Nougairède, Antoine
Publicado 2022

Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19

por Assmus, Frauke, Driouich, Jean-Sélim, Abdelnabi, Rana, Vangeel, Laura, Touret, Franck, Adehin, Ayorinde, Chotsiri, Palang, Cochin, Maxime, Foo, Caroline S., Jochmans, Dirk, Kim, Seungtaek, Luciani, Léa, Moureau, Grégory, Park, Soonju, Pétit, Paul-Rémi, Shum, David, Wattanakul, Thanaporn, Weynand, Birgit, Fraisse, Laurent, Ioset, Jean-Robert, Mowbray, Charles E., Owen, Andrew, Hoglund, Richard M., Tarning, Joel, de Lamballerie, Xavier, Nougairède, Antoine, Neyts, Johan, Sjö, Peter, Escudié, Fanny, Scandale, Ivan, Chatelain, Eric
Publicado 2022